Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Abstract Background Due to the lack of effective therapies and poor prognosis in TNBC (triple-negative breast cancer) patients, there is a strong need to develop effective novel targeted therapies for this subtype of breast cancer. Inhibition of heat shock protein 90 (HSP90), a conserved molecular c...
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMC
2019-01-01
|
Edice: | BMC Cancer |
Témata: | |
On-line přístup: | http://link.springer.com/article/10.1186/s12885-019-5295-z |